Otolith Labs Announces $20M Series A
Summary
WASHINGTON, DC, Otolith Labs, a medical technology company, announced the closing of a $20 million Series A financing round by Morningside Ventures.. Otolith Labs, a medical technology company developing noninvasive wearable medical devices for the treatment of vestibular disorders, announced the closing of a $20 million Series A financing round by Morningside Ventures. Building on prior investments from businessman Mark Cuban and leading ENT physicians, the proceeds will be used to support the companys ongoing clinical programs, anticipated FDA approval and first commercial launch of a prescription wearable device using its noninvasive Vestibular System Masking (nVSM) technology for the treatment of chronic vertigo. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.